Images List Premium Download Classic

Immune Response

Immune Response-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Rna-based compositions and adjuvants for prophylactic and therapeutic treatment
University Of Kentucky Research Foundation
June 22, 2017 - N°20170175122

The present invention is directed towards an artificial rna nanostructure comprising multiple external strands of rna, each external strand comprising about 40-50 nucleotides; one internal strand of rna comprising more than about 50 nucleotides; the internal strands and external strands assembled to form a triangle nanostructure, a square nanostructure, or a polygon nanostructure and a prna three-way junction (3wj) motif at ...
Self assembling nucleic acid nanostructures
Exicure, Inc.
June 22, 2017 - N°20170175121

Stable self-assembling nucleic acid nanostructures comprising: —a plurality of oligonucleotides, —a plurality of g-quadruplex forming nucleic acids linked to the plurality of oligonucleotides, and —a plurality of g-quadruplex stabilizing domains linked to the g-quadruplex forming nucleic acids. The nucleic acid nanostructures are suitable for use as agonists or antagonists of nucleic acid interacting complexes, such as toll-like ...
Compositions and methods relating to the treatment of diseases
Alfacyte Ltd
June 22, 2017 - N°20170174735

The present invention relates to compositions and methods for promoting the induction of a cell-mediated immune response (such as that mediated by th1 cells) and the suppression of a humoral or allergic immune response (such as that mediated by th2 and th17 cells). In particular, the invention relates to compositions and methods for preventing or treating allergy, such as food ...
Immune Response Patent Pack
Download 464+ patent application PDFs
Immune Response Patent Applications
Download 464+ Immune Response-related PDFs
For professional research & prior art discovery
inventor
  • 464+ full patent PDF documents of Immune Response-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Treatment of infection
Los Angeles Biomedical Research Institute At Harbor-ucla Medical Center
June 22, 2017 - N°20170173148

The invention relates to compositions including a substance useful as an adjuvant for potentiating an immune response, and methods of using the composition in individuals with infections of tissue within or adjacent to a transformation zone, such as the transformation zone of the cervix or anal canal.
Vaccine
Moredun Research Institute
June 22, 2017 - N°20170173139

The present invention is based on the finding that microorganisms can be modified so as to express certain factors important in generating or raising host immune responses. In particular, the invention provides modified microorganisms which, when subjected to conditions which would be expected to suppress or reduce the expression, function and/or activity of certain factors, exhibit increased (often significantly ...
Immune health for companion animals
Nestec Sa
June 22, 2017 - N°20170173138

The invention provides methods for promoting and/or improving immune health in a companion animal. In one embodiment, a method for improving immune health in a companion animal, comprising administering a composition comprising non-replicating lactobacillus paracasei to the companion animal, wherein the composition is administered in an amount effective for increasing immune response in the animal.
Immune Response Patent Pack
Download 464+ patent application PDFs
Immune Response Patent Applications
Download 464+ Immune Response-related PDFs
For professional research & prior art discovery
inventor
  • 464+ full patent PDF documents of Immune Response-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Novel peptides and combination of peptides for use in immunotherapy against cll and other cancers
Immatics Biotechnologies Gmbh
June 22, 2017 - N°20170173131

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated t-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor ...
Identification of pneumocystis antigens and uses thereof
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College
June 22, 2017 - N°20170173126

Pneumonia due to the fungus pneumocystis jirovecii is a life-threatening infection that occurs in immunocompromised patients. The inability to culture the organism as well as the lack of a sequenced genome has hindered antigen discovery that could be useful in developing effective vaccines, therapeutic antibodies and diagnostic methods. A method of surface proteomics of pneumocystis murina that reliably detects surface ...
Immunotherapeutic composition, method of treatment, and method of diagnosis
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College
June 22, 2017 - N°20170173116

Disclosed herein is a immunotherapeutic composition comprising il-17. Also disclosed herein is a method of increasing an immune response in a subject in need thereof. The method may include administering the immunotherapeutic composition to the subject. The increased immune response may protect against an influenza virus. Further disclosed herein is a method of diagnosing influenza viral infection.
Method and system for treating cancer cachexia
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College
June 22, 2017 - N°20170173085

Various embodiments of the present invention are directed to the field of oncology, and in particular embodiments directed to a method of ameliorating, treating, or preventing a malignancy in a human subject wherein the steps of the method assist or boost the immune system in eradicating cancerous cells. In certain embodiments, administration of beneficial bacteria to an individual's microbiome that ...
Immune-modifying nanoparticles for the treatment of inflammatory diseases
Cour Pharmaceuticals Development Company, Inc.
June 22, 2017 - N°20170173071

The current invention involves the administration of negatively charged particles, such as polystyrene, plga, or diamond particles, to subjects to ameliorate inflammatory immune responses. Additionally, the present invention describes methods of treating inflammatory diseases by administering these same negatively charged particles.
Early cancer detection and enhanced immunotherapy
Cour Pharmaceuticals Development Company, Inc.
June 22, 2017 - N°20170172932

A method of therapy for a tumor or other pathology by administering a combination of thermotherapy and immunotherapy optionally combined with gene delivery. The combination therapy beneficially treats the tumor and prevents tumor recurrence, either locally or at a different site, by boosting the patient's immune response both at the time or original therapy and/or for later therapy. With ...
Methods for treating cancer
Cour Pharmaceuticals Development Company, Inc.
June 15, 2017 - N°20170166978

A method for treating cancer comprising the steps of genetically sequencing a patient healthy tissue, genetically sequencing a patient tumor tissue, comparing the genetic sequences of the healthy tissue and tumor tissue to identify one or more mutations specific to the tumor tissue, generating a library of 9-mers having one or more peptide fragments specific to the tumor tissue, and ...
Immune Response Patent Pack
Download 464+ patent application PDFs
Immune Response Patent Applications
Download 464+ Immune Response-related PDFs
For professional research & prior art discovery
inventor
  • 464+ full patent PDF documents of Immune Response-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule
Institut National De La Sante Et De La Research Medical (inserm)
June 15, 2017 - N°20170166623

The invention relates to the regulated expression of a chimeric antigen receptor (car) within a lentiviral vector. The car comprises a hook-binding domain that interacts with a hook, preferably encoded by the same lentiviral vector, which prevents proper processing and release of the car to the cell membrane. The invention encompasses vectors, methods of making the vectors, and methods of ...
Immunostimulatory combinations of tlr ligands and methods of use
The United States Of America, As Represented By The Secretary, Department Of Health & Human Servic
June 15, 2017 - N°20170165359

The present invention provides immunostimulatory combinations of tlr ligands and therapeutic and/or prophylactic methods that include administering an immunostimulatory combination to a subject. In general, the immunostimulatory combinations described herein can provide an increased immune response compared to other immunostimulatory combinations and/or compositions.
Immunotherapy composition and use thereof
Ondek Pty Ltd
June 15, 2017 - N°20170165357

The present invention relates to the field of preventing or reducing incidence or severity of an allergic immune response, and compositions for preventing or reducing incidence or severity of an allergic immune response. For example, the present invention provides compositions comprising inactivated and/or killed cells of helicobacter pylori or a cell lysate thereof, and methods and/or uses thereof ...
Novel vaccines against multiple subtypes of influenza virus
The Trustees Of The University Of Pennsylvania
June 15, 2017 - N°20170165353

An aspect of the present invention is directed towards dna plasmid vaccines capable of generating in a mammal an immune response against a plurality of influenza virus subtypes, comprising a dna plasmid and a pharmaceutically acceptable excipient. The dna plasmid is capable of expressing a consensus influenza antigen in a cell of the mammal in a quantity effective to elicit ...
Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same
The Trustees Of The University Of Pennsylvania
June 15, 2017 - N°20170165350

Nucleic acid molecules and compositions comprising one or more nucleic acid sequences that encode a consensus filovirus immunogen including a consensus marburgvirus filovirus glycoprotein marv gp immunogen, a consensus ebolavirus sudan filovirus glycoprotein sebov gp immunogen and a consensus ebolavirus zaire glycoprotein zebov gp immunogen are disclosed. The coding sequences optionally include operable linked coding sequence that encode a signal ...
Aipa, ompa, and asp14 in vaccine compositions and diagnostic targets for anaplasma phagocytophilum infection
Virginia Commonwealth University
June 15, 2017 - N°20170165342

Anaplasma phagocytophilum surface protein aipa and/or fragments thereof which comprise an invasin domain are used in compositions suitable to elicit an immune response to treat or prevent infections caused by tick-born bacteria of the anaplasmatacaea family. Aipa proteins and protein fragments or antibodies directed to aipa proteins and protein fragments are also used in diagnostic assays to detect exposure ...
Replication defective adenovirus vector in vaccination
Etubics Corporation
June 15, 2017 - N°20170165341

Methods for generating immune responses using adenovirus vectors that allow multiple vaccinations with the same adenovirus vector and vaccinations in individuals with preexisting immunity to adenovirus are provided.
Novel peptides and combination of peptides for use in immunotherapy against cll and other cancers
Immatics Biotechnologies Gmbh
June 15, 2017 - N°20170165340

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated t-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor ...
Loading